Search

Search Results

• 

  Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  https://doi.org/10.4081/reumatismo.2024.1701

  1204

  PDF: 384
• 

  How the ultrasound protocol may improve the timely diagnosis of cerebrovascular complications in giant cell arteritis

  Beatrice Maranini, Maura Pugliatti, Marcello Govoni

  08-07-2025

  https://doi.org/10.4081/reumatismo.2025.1831

  1637

  PDF: 117
• 

  Clinical features of gout

  W. Grassi, R. De Angelis

  238-245

  https://doi.org/10.4081/reumatismo.2011.238

  4974

  PDF: 3927

• CO:11:2 | Systemic lupus erythematosus with major neuropsychiatric involvement treated with anifrolumab: literature review and a case report Giulia Rizzo¹, Fabio Congiu¹, Elisabetta Chessa², Marta Paola Pireddu¹, Elena Ragusa¹, Alessandra Oliva¹, Marianna Salis¹, Alberto Cauli^1|2, Matteo Piga^1|2 | ¹SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari Italy; ²SC Reumatologia, AOU Cagliari Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2120

  221

• PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study Alessandro Tomelleri¹, Durga Prasanna Misra², Fatma Alibaz-Oner³, Chiara Marvisi⁴, Chiara Calabrese¹, Upendra Rathore², Aysegul Avcu³, Adele Del Giudice⁴, Elisabetta Olivi⁴, Caterina Ricordi⁴, Corrado Campochiaro¹, Elena Baldissera¹, Marco Matucci-Cerinic¹, Haner Direskeneli³, Carlo Salvarani⁴, Lorenzo Dagna¹ | ¹IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; ²Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; ³Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; ⁴Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2389

  26

• PO:12:179 | Cardiovascular outcomes of treat-to-target urate-lowering therapy in gout: emulated target trials Edoardo Cipolletta¹, Davide Rozza², Abhishek Abhishek³ | ¹Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy; ²Società Italiana di Reumatologia, Milano, Italy; ³University of Nottingham Nottingham, United Kingdom

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2314

  43
• 

  Sex and gender differences in comorbidities in spondyloarthritis: a focus on psoriatic arthritis

  F. Atzeni, C. Siragusano, A. Tropea, A. Alciati

  11-09-2024

  https://doi.org/10.4081/reumatismo.2024.1769

  1955

  PDF: 685
• 

  Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet’s disease and autoinflammation. A viewpoint

  A. Colangelo, F. Tromby, G. Cafaro, R. Gerli, E. Bartoloni, C. Perricone

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1578

  2016

  PDF: 1189

• PO:25:075 | Cancer occurence in patients with idiopathic inflammatory myopathies: new insights from the analysis of a monocentric cohort Michele Diomedi¹, Federico Fattorini¹, Simone Barsotti², Chiara Cardelli^1|3, Elenia Laurino⁴, Alessandra Tripoli⁴, Linda Carli⁴, Marta Mosca^1|4. | ¹Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; ²Rheumatology, Versilia Hospital, Viareggio, Italy; ³Department of Medical Biotechnologies, University of Siena, Siena, Italy; ⁴Rheumatology Unit, AOUP, Pisa, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2063

  140